Logue identified by whole exome sequencing a small number of AA AD cases and subsequent genotyping in a large AA sample of AD cases and controls association of AD risk with a pair of rare missense variants in AKAP9 [34]. This evidence concerns the gene AKAP9 and Alzheimer disease.